Ejemel, Monir
Li, Qi
Hou, Shurong http://orcid.org/0000-0001-5143-0797
Schiller, Zachary A. http://orcid.org/0000-0002-4185-2416
Tree, Julia A.
Wallace, Aaron
Amcheslavsky, Alla
Kurt Yilmaz, Nese
Buttigieg, Karen R.
Elmore, Michael J. http://orcid.org/0000-0001-9425-2660
Godwin, Kerry
Coombes, Naomi
Toomey, Jacqueline R.
Schneider, Ryan
Ramchetty, Anudeep S.
Close, Brianna J. http://orcid.org/0000-0002-0563-1464
Chen, Da-Yuan
Conway, Hasahn L. http://orcid.org/0000-0001-7328-3521
Saeed, Mohsan
Ganesa, Chandrashekar
Carroll, Miles W.
Cavacini, Lisa A. http://orcid.org/0000-0003-1417-8339
Klempner, Mark S.
Schiffer, Celia A. http://orcid.org/0000-0003-2270-6613
Wang, Yang http://orcid.org/0000-0002-5554-8247
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NO1-AI-65315)
Article History
Received: 5 May 2020
Accepted: 3 August 2020
First Online: 21 August 2020
Competing interests
: A patent application has been filed on 5 May 2020 on monoclonal antibodies targeting SARS-CoV-2 (U.S. Patent and Trademark Office patent application no. 63/020,483; patent applicants: Y.W., M.E., Q.L., and M.K., University of Massachusetts Medical School). The remaining authors declare no competing interests.